ACC25: New research explores top treatments, trials, and trends discussed by HCPs on social media

New research by Creation Healthcare has found almost 2,000 healthcare professionals from across the globe used their social media platforms to engage with the latest cardiology news presented and shared at the American College of Cardiology’s (ACC25) 74th annual Scientific Session & Expo in Chicago.

The digital insights consultancy’s research identified over 1,800 HCPs who posted a total of more than 8,000 social media posts in the run-up to and during the three-day conference.

US-based HCPs were the most active in online conversations, responsible for 62 per cent of social media posts, followed by Spain at five per cent and the United Kingdom at four per cent.

Despite conversation being dominated by US HCPs, the most active individual was Dr. Hany Ragy, an Egyptian cardiologist, who shared 189 original posts by the end of the conference. Dr Ragy drove 89 per cent of Egyptian HCP engagement, with a potential reach of over 500,000.

He was followed by Dr. Amitabh Pandey, an American cardiologist, who posted 179 times, and Dr. Eolo Morandi Jr., a Brazilian cardiologist who shared 161 posts in relation to the congress. Dr Morandi was responsible for 77 per cent of Brazilian HCP social media posts from the conference.

HCPs’ online conversations at ACC25

According to the study, HCPs actively engaged in online conversations about ACC in the two weeks leading up to the event, with more than 400 HCPs sharing 1,259 posts before the conference began.

On the opening day of the conference, March 29, the volume of online conversations among healthcare professionals saw a huge spike. Social media posts covered a range of topics from advancements in AI to the role of social media in professional development. 

The first spike was driven by mentions of the WARRIOR trial, which was mentioned by 35 HCPs, and STRIDE trial, which was mentioned 45 times. Dr. Hany Ragy posted 62 times that day, with 18 per cent of these posts making reference to WARRIOR and STRIDE trials.

Subsequent spikes in online conversations throughout the conference were driven by unique factors each day. Product mentions, including Semaglutide and Dapaglifozin, proved prominent, as did the use of different hashtags used throughout the conference, such as #cardiotwitter, #heartfailure. Research presented in Late-Breaking Clinical Trial (LBCT) sessionswere also a key contributor to the high volume of conversation, especially in the context of heart failure management.

Sources, mentions, and trends

Creation Healthcare found that scientific sources were the most trusted in online conversation. HCPs frequently cited accounts such as ACCintouch – referenced more than 3,041 times – and renowned journals including JACC and NEJM. The most shared post came from NEJM, entitled “Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes,” with 108 shares by HCPs, reaching a total of 1,551,083 accounts worldwide.

Healthcare professionals also acknowledged their peers in many of their posts. Cardiologist Dr. Martha Gulati was the most-tagged by fellow HCPs, closely followed by Mamas A. Mamas. Both were tagged over 200 times by other HCPs.

The study also found that HCPs used a range of hashtags to discuss cross-disciplinary topics, gender representation in the field, and the most significant cardiovascular research. #ACC25 proved the most used hashtag by a considerable distance. This was followed by #CardioTwitter – an online community where HCPs share knowledge with their peers.

Other hashtags used included #ACCFit, which was used in discussions about leadership development in cardiology and #ACCWIC, which highlighted Women in Cardiology sessions. Social media posts using the #ACCWIC hashtag discussed breaking barriers, strengthening networks, and promoting mentorship for female professionals. Many female HCPs also shared photos from these sessions where they celebrated colleagues, exchanged ideas, and promoted a supportive community.

Among manufacturers, Creation Healthcare found that Novo Nordisk was the most-mentioned throughout ACC, with some HCPs highlighting the competitive treatment landscape in the obesity space. Merck proved the second most-mentioned, with online conversations noting its partnership with ACC and phase 3 ZENITH trial results.

Commenting on the research, Creation Healthcare’s CEO, Daniel Ghinn, said:

“The ACC25 conference provides just another example of the key role social media plays in facilitating discussions among healthcare professionals about the most recent developments in healthcare – in this case in the cardiovascular space.

“With over 8,000 posts from 1,800 HCPs, it is evident that X is still a key platform for cardiologists to exchange ideas, discuss clinical trials, and engage with their peers from across the globe.

“There was a huge buzz around ACC25, and tracking these conversations is invaluable in understanding the values and priorities of those on the frontlines of healthcare delivery.”

ENDS

About Creation Healthcare

Creation Healthcare provides insights and consulting to inform health strategy, communications, and policymaking among some of the world’s largest healthcare companies, government organizations and NGOs. 

This is made possible through CREATION Pinpoint®, the world’s only AI-powered global database of more than 3 million healthcare professionals’ social media profiles, analyzing the collective intelligence of almost 2 billion social media posts by professionals on the front lines of healthcare.  

For further media enquiries 

William Walter, Managing Director, Bridgehead Communications 

[email protected]

+44 (0) 7971 441 735